Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.200
-0.020 (-1.64%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Climb Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 87.23 | 93.11 | 43.59 | 46.92 | 20.49 | Upgrade
|
| Short-Term Investments | 63.69 | 13.69 | 79.98 | 89.56 | - | Upgrade
|
| Cash & Short-Term Investments | 150.92 | 106.8 | 123.57 | 136.48 | 20.49 | Upgrade
|
| Cash Growth | 41.31% | -13.57% | -9.46% | 566.18% | -3.47% | Upgrade
|
| Other Receivables | 1.12 | 2.46 | 6.59 | 7.02 | - | Upgrade
|
| Receivables | 1.12 | 2.46 | 6.59 | 7.02 | - | Upgrade
|
| Prepaid Expenses | 0.72 | 0.85 | 3.88 | 4.4 | 1.5 | Upgrade
|
| Other Current Assets | 2.11 | 0.15 | 0.36 | 0.35 | 0.01 | Upgrade
|
| Total Current Assets | 154.87 | 110.26 | 134.39 | 148.25 | 22 | Upgrade
|
| Property, Plant & Equipment | 0.49 | 0.2 | 0.47 | - | - | Upgrade
|
| Long-Term Investments | 61.61 | - | - | 24.92 | - | Upgrade
|
| Other Long-Term Assets | 0.22 | 0.02 | 0.13 | 0.07 | 2.63 | Upgrade
|
| Total Assets | 217.19 | 110.47 | 134.99 | 173.24 | 24.63 | Upgrade
|
| Accounts Payable | 0.71 | 0.07 | 0.75 | 1.4 | 1.29 | Upgrade
|
| Accrued Expenses | 4.04 | 1.23 | 5.05 | 4.63 | 1.22 | Upgrade
|
| Current Portion of Leases | 0.16 | 0.33 | 0.3 | - | - | Upgrade
|
| Other Current Liabilities | 0.03 | 1.2 | - | - | - | Upgrade
|
| Total Current Liabilities | 4.93 | 2.83 | 6.1 | 6.03 | 2.51 | Upgrade
|
| Long-Term Leases | 0.38 | 0.02 | 0.18 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | 0.02 | - | 0.01 | - | Upgrade
|
| Total Liabilities | 5.31 | 2.87 | 6.28 | 6.04 | 2.51 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 441.73 | 263.58 | 249.93 | 242.94 | 3.15 | Upgrade
|
| Retained Earnings | -229.88 | -155.98 | -120.86 | -75.62 | -28.14 | Upgrade
|
| Comprehensive Income & Other | 0.02 | -0 | -0.36 | -0.12 | - | Upgrade
|
| Total Common Equity | 211.88 | 107.6 | 128.72 | 167.2 | -24.98 | Upgrade
|
| Shareholders' Equity | 211.88 | 107.6 | 128.72 | 167.2 | 22.12 | Upgrade
|
| Total Liabilities & Equity | 217.19 | 110.47 | 134.99 | 173.24 | 24.63 | Upgrade
|
| Total Debt | 0.53 | 0.35 | 0.48 | - | - | Upgrade
|
| Net Cash (Debt) | 212 | 106.45 | 123.09 | 161.4 | 20.49 | Upgrade
|
| Net Cash Growth | 99.15% | -13.52% | -23.74% | 687.81% | -3.47% | Upgrade
|
| Net Cash Per Share | 4.40 | 3.94 | 4.68 | 13.16 | 9.36 | Upgrade
|
| Filing Date Shares Outstanding | 67.48 | 27.72 | 26.57 | 26.57 | 3.48 | Upgrade
|
| Total Common Shares Outstanding | 67.26 | 27.7 | 26.57 | 26.24 | 3.42 | Upgrade
|
| Working Capital | 149.94 | 107.42 | 128.3 | 142.22 | 19.49 | Upgrade
|
| Book Value Per Share | 3.15 | 3.88 | 4.84 | 6.37 | -7.31 | Upgrade
|
| Tangible Book Value | 211.88 | 107.6 | 128.72 | 167.2 | -24.98 | Upgrade
|
| Tangible Book Value Per Share | 3.15 | 3.88 | 4.84 | 6.37 | -7.31 | Upgrade
|
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.